
Dr. Dharma Choudhary is a senior Haematologist and Bone Marrow Transplant specialist serving as Chairman of the Centre for Bone Marrow Transplant at BLK-Max Super Speciality Hospital, New Delhi. With more than 23 years of professional experience, he specialises in the treatment of blood cancers, bone marrow disorders and complex conditions requiring stem cell transplantation.
He completed his MBBS and MD in Internal Medicine, followed by a DM in Clinical Haematology from the All India Institute of Medical Sciences (AIIMS), New Delhi. His additional specialist training includes haematology at Christian Medical College, Vellore, clinical immunology at SGPGIMS, Lucknow, and advanced leukaemia and bone marrow transplant training in Vancouver, Canada.
His clinical expertise includes allogeneic and haploidentical bone marrow transplantation, stem cell transplantation, treatment of leukaemia and lymphoma, multiple myeloma, thalassaemia and aplastic anaemia. He also has specialist experience in managing graft-versus-host disease and complex bone marrow failure syndromes.
Dr. Choudhary has played an important role in developing bone marrow transplant programmes at BLK-Max Super Speciality Hospital and Sanar International Hospital, Gurugram. He has also contributed to medical research, professional publications and postgraduate training in haematology and bone marrow transplantation.
Decades of expertise, proven results, and compassionate care — here is why patients from 50+ countries trust Dr. Dharma Choudhary for Hematology & BMT treatment in India.
Over 20 years of dedicated clinical experience with 5,000+ procedures. One of the most trusted names in Hematology & BMT in India.
Dr. Dharma Choudhary regularly treats patients from Africa, the Middle East, Central Asia, and Europe. Dedicated international patient support team available 24/7.
Practices at an internationally accredited hospital, ensuring patient safety standards that match the best hospitals in the USA and Europe.
World-class treatment at a fraction of USA, UK, or Australian prices. Transparent cost estimates provided before you travel.
Dr. Dharma Choudhary holds postgraduate qualifications from premier Indian institutions and has advanced fellowship training in Hematology & BMT.
Every case is personally reviewed. Treatment plans are tailored, transparent, and discussed in detail before you make any decisions or travel arrangements.
AML, CML, CLL, ALL, Hodgkin & Non-Hodgkin Lymphoma, Multiple Myeloma — treated with chemotherapy, targeted therapy & BMT.
Autologous, allogeneic, and haplo-identical BMT for leukemia, lymphoma, aplastic anemia, and inherited blood disorders.
Cutting-edge immunotherapy using genetically modified T-cells for blood cancers that have relapsed after standard treatments.
Curative BMT for thalassemia major and sickle cell anemia in children and adults. Low-cost programs available across India.
Both immunosuppressive therapy and stem cell transplantation for severe and very severe aplastic anemia, including pediatric cases.
HSCT (Hematopoietic Stem Cell Transplant) for aggressive Multiple Sclerosis — a disease-modifying treatment available in India.
Expert care for childhood leukemia, thalassemia, ITP, and inherited bone marrow failure syndromes.
Diagnosis and treatment of bone marrow failure and pre-leukemia syndromes with modern protocols.
Comprehensive management of hemophilia A & B, Von Willebrand disease, platelet disorders, and coagulopathies.
The most complex and potentially curative form of BMT where stem cells come from a matched donor. Used for leukemia, aplastic anemia, and inherited blood disorders.
Patient's own stem cells are harvested and reinfused after high-dose chemotherapy. Used for multiple myeloma and relapsed lymphomas.
Revolutionary immunotherapy where the patient's own T-cells are genetically reprogrammed to attack cancer cells.
The only curative treatment for beta-thalassemia major and sickle cell disease through allogeneic stem cell transplantation.
Personalised chemotherapy and next-generation targeted agents for lymphoma, leukaemia, and related disorders.
Send your medical reports and get a personalised treatment plan. The team reviews cases from 50+ countries and responds within 24 hours.
Our team responds within 24 hours
Share your reports and receive a personalised treatment recommendation within 48 hours — at no cost.